Improving Sleep in a Psychiatric Hospital
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-90
SponsorThe University of Texas Health Science Center, Houston
About this trial
The purpose of this study is to examine effects of sleep promotion versus treatment as usual (TAU) on subjective, self-reported sleep while in inpatient psychiatric treatment, to examine effects of sleep promotion vs. TAU/sleep disruption on self-reported depression, anxiety, suicide risk across inpatient length of stay, readmission at 72 hours, objective sleep and to compare implementation outcomes of acceptability and feasibility of sleep promotion relative to TAU/sleep disruption as reported by patients, clinicians, and clinic leaders using mixed methods.
Eligibility criteria
Qualifiers
Admitted voluntarily to inpatient psychiatric hospital for suicidal ideation or behavior.
Continue to express suicide risk on the Suicide Behaviors Questionnaire-Revised (SBQ-R) of ≥8 at admission.
Cognitive ability as tested by the Montreal Cognitive Assessment (MoCA) of > 23.
Have sufficient communication and comprehension ability to consent to the study
Disqualifiers
Intellectual disability/unable to give informed consent.
Patients with one-to-one supervision or 15-minute (Q15) safety checks for suicidality or aggression will be unable to enroll in the study until these restrictions are discontinued.
Patients with roommates that are on one-to-one supervision or Q15 safety checks for suicidality or aggression.
Patients enrolled in the study with a patient admitted as their roommate who requires one-to-one supervision or Q15 checks-Patient will be unenrolled if a room change is not possible.
Trial design
Treatments tested in this trial
- Scented Oil
- Ear Plugs
- Eye Mask
- Video based safety check
- In person safety check
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov